Cindy Serdjebi

1.1k total citations
24 papers, 787 citations indexed

About

Cindy Serdjebi is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cindy Serdjebi has authored 24 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cindy Serdjebi's work include Pancreatic and Hepatic Oncology Research (6 papers), Biochemical and Molecular Research (5 papers) and Cancer Genomics and Diagnostics (5 papers). Cindy Serdjebi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Biochemical and Molecular Research (5 papers) and Cancer Genomics and Diagnostics (5 papers). Cindy Serdjebi collaborates with scholars based in France, Switzerland and Netherlands. Cindy Serdjebi's co-authors include Joseph Ciccolini, Godefridus J. Peters, Elisa Giovannetti, Raphaëlle Fanciullino, Sarah Giacometti, G. Milano, Nicolás André, Eddy Pasquier, Marie-Pierre Montero and Manon Carré and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Cindy Serdjebi

24 papers receiving 781 citations

Peers

Countries citing papers authored by Cindy Serdjebi

Since Specialization

Citations

This map shows the geographic impact of Cindy Serdjebi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cindy Serdjebi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cindy Serdjebi more than expected).

Fields of papers citing papers by Cindy Serdjebi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cindy Serdjebi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cindy Serdjebi. The network helps show where Cindy Serdjebi may publish in the future.

Co-authorship network of co-authors of Cindy Serdjebi

This figure shows the co-authorship network connecting the top 25 collaborators of Cindy Serdjebi. A scholar is included among the top collaborators of Cindy Serdjebi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cindy Serdjebi. Cindy Serdjebi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Selective adipocyte loss of Angiopoietin-2 prompts female-specific obesity and metabolic syndrome 2022 ·Molecular Metabolism ·(unknown), Shanshan Chen, Kathleen A. Ryan, Michael L. Maitland, Jared S. Farrar, Martin Witzenrath, (unknown), Cindy Serdjebi, (unknown), Rui Wang, Fadi N. Salloum, Luigi Marino, Braxton D. Mitchell, Francesco S. Celi	4
2	Cigarette smoke-induced gasdermin D activation in bronchoalveolar macrophages and bronchial epithelial cells dependently on NLRP3 2022 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), (unknown), Florence Savigny, (unknown), Cindy Serdjebi, Marc Le Bert, Valérie Quesniaux, Bernhard Ryffel, Petr Brož, Nicolas Riteau, Aurélie Gombault, Isabelle Couillin	17
3	GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition 2020 ·Therapeutic Advances in Chronic Disease ·Eloïne Bestion, Zuzana Macek Jílková, Jean‐Louis Mège, (unknown), Keerthi Kurma, (unknown), Gilles Lalmanach, (unknown), Lionel Fizanne, (unknown), (unknown), (unknown), Jérôme Boursier, Jérôme Courcambeck, Cindy Serdjebi, (unknown), Thomas Decaens, Philippe Halfon, Sonia Brun	11
4	Quantitative mathematical modeling of clinical brain metastasis dynamics in non-small cell lung cancer 2019 ·Scientific Reports ·Mariia Bilous, Cindy Serdjebi, Alexandre Boyer, Pascale Tomasini, (unknown), Dominique Barbolosi, Fabrice Barlési, François Chomy, Sébastien Benzekry	20
5	GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma 2019 ·Investigational New Drugs ·Sonia Brun, (unknown), Cindy Serdjebi, (unknown), (unknown), (unknown), (unknown), (unknown), Jérôme Courcambeck, (unknown), Éric Raymond, (unknown)	25
6	Pharmacokinetics and Pharmacodynamics-Based Mathematical Modeling Identifies an Optimal Protocol for Metronomic Chemotherapy 2017 ·Cancer Research ·Joseph Ciccolini, Dominique Barbolosi, Christophe Meille, (unknown), Cindy Serdjebi, Sarah Giacometti, Laëtitia Padovani, Eddy Pasquier, Nicolás André	29
7	In Vivo Bioluminescence Tomography for Monitoring Breast Tumor Growth and Metastatic Spreading: Comparative Study and Mathematical Modeling 2016 ·Scientific Reports ·Séverine Mollard, Raphaëlle Fanciullino, Sarah Giacometti, Cindy Serdjebi, Sébastien Benzekry, Joseph Ciccolini	19
8	Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective 2016 ·Cancer Chemotherapy and Pharmacology ·Joseph Ciccolini, Cindy Serdjebi, Godefridus J. Peters, Elisa Giovannetti	167
9	Nucleoside analogs: ready to enter the era of precision medicine? 2016 ·Expert Opinion on Drug Metabolism & Toxicology ·Joseph Ciccolini, Cindy Serdjebi, (unknown), Bruno Lacarelle, G. Milano, Raphaëlle Fanciullino	12
10	EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer 2016 ·International Journal of Molecular Sciences ·Pascale Tomasini, Cindy Serdjebi, (unknown), Philippe Métellus, L’Houcine Ouafik, Isabelle Nanni, Laurent Greillier, Anderson Loundou, Fréderic Fina, Céline Mascaux, Fabrice Barlési	50
11	Lethal toxicity after administration of azacytidine 2015 ·Pharmacogenetics and Genomics ·(unknown), Cédric Mercier, Cindy Serdjebi, (unknown), Fréderic Fina, L’Houcine Ouafik, Bruno Lacarelle, Joseph Ciccolini, Régis Costello	11
12	Pharmacogenetics and breast cancer management: current status and perspectives 2015 ·Expert Opinion on Drug Metabolism & Toxicology ·Joseph Ciccolini, Raphaëlle Fanciullino, Cindy Serdjebi, G. Milano	9
13	FFCD-1004 Clinical Trial: Impact of Cytidine Deaminase Activity on Clinical Outcome in Gemcitabine-Monotherapy Treated Patients 2015 ·PLoS ONE ·Cindy Serdjebi, Johan Gagnière, Jérôme Desrame, Francine Fein, Rosine Guimbaud, E. François, Thierry André, Jean‐François Seitz, (unknown), Dominique Arsène, Julien Volet, (unknown), Thierry Lecomte, Véronique Guerin‐Meyer, Jean-Louis Legoux, G. Deplanque, Pierre Guillet, Joseph Ciccolini, Côme Lepage, Laëtitia Dahan	20
14	Role of cytidine deaminase in toxicity and efficacy of nucleosidic analogs 2014 ·Expert Opinion on Drug Metabolism & Toxicology ·Cindy Serdjebi, G. Milano, Joseph Ciccolini	54
15	Recipient/donor contradictory genotypes with impact on drug pharmacogenetics after liver transplant 2014 ·Pharmacogenetics and Genomics ·Cindy Serdjebi, Joseph Ciccolini, Fréderic Fina, (unknown), Arnauld Verschuur, Bruno Lacarelle, L’Houcine Ouafik, Nicolás André	3
16	Selection of the Best Blood Compartment to Measure Cytidine Deaminase Activity to Stratify for Optimal Gemcitabine or Cytarabine Treatment 2014 ·Nucleosides Nucleotides & Nucleic Acids ·Godefridus J. Peters, Richard J. Honeywell, (unknown), Elisa Giovannetti, Nienke Losekoot, Marie-Christine Étienne-Grimaldi, G. Milano, Cindy Serdjebi, Joseph Ciccolini, (unknown)	20
17	Biodistribution, Tumor Uptake and Efficacy of 5-FU-Loaded Liposomes: Why Size Matters 2014 ·Pharmaceutical Research ·Raphaëlle Fanciullino, Séverine Mollard, Florian Corréard, Sarah Giacometti, Cindy Serdjebi, Athanassios Iliadis, Joseph Ciccolini	24
18	Abstract 2208: Cytidine deaminase deficiency and severe toxicities upon aza-cytidine intake: Clinical observations and experimental evidences. 2013 ·Cancer Research ·(unknown), Cindy Serdjebi, Séverine Mollard, Régis Costello, L’Houcine Ouafik, Joseph Ciccolini, Cédric Mercier	2
19	Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines 2011 ·Oncogene ·Renaud Grépin, (unknown), Marion Jacquin, Jérôme Durivault, Emmanuel Chamorey, Anne Sudaka, Cindy Serdjebi, Bruno Lacarelle, (unknown), Sylvie Négrier, Hélène Simonnet, Gilles Pagès	49
20	Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment 2011 ·Oncotarget ·Eddy Pasquier, Joseph Ciccolini, Manon Carré, Sarah Giacometti, Raphaëlle Fanciullino, (unknown), Marie-Pierre Montero, Cindy Serdjebi, Maria Kavallaris, Nicolás André	187

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact